149 related articles for article (PubMed ID: 37422200)
1. Successful treatment of non-melanoma skin cancer in three patients with Xeroderma Pigmentosum by modified ALA-PDT.
Zheng J; Liu W; Zhou Z; Cao Z; Zhao Z; Wang X; Li M; Zhang G
Photodiagnosis Photodyn Ther; 2023 Sep; 43():103694. PubMed ID: 37422200
[TBL] [Abstract][Full Text] [Related]
2. Daylight photodynamic therapy is an option for the treatment of actinic keratosis in patients with xeroderma pigmentosum in Africa.
Fernández-Guarino M; Mavura D; Fernández-González P; Chapa P; Ravazzano C; Jaén L; Rios L; Jaén P; Grossman H
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101631. PubMed ID: 31904551
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy in the treatment of xeroderma pigmentosum: A case report.
Cai H; Yang QQ; Ma C; Zou DX; Wang YX; Sun P; Ju AQ; Fang F; Gong S; Liu W
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101761. PubMed ID: 32283311
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy in a teenage girl with xeroderma pigmentosum type C.
Larson DM; Cunningham BB
Pediatr Dermatol; 2012; 29(3):373-4. PubMed ID: 22277026
[TBL] [Abstract][Full Text] [Related]
5. ALA-PDT successfully treated multiple cSCC in situ and AK in a patient with Epidermodysplasia verruciformis.
Zhao Z; Wu Y; Zhou Z; Zhao Y; Sun X; Hu C; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102395. PubMed ID: 34126243
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
7. Recurrent squamous cell carcinoma and a novel mutation in a patient with xeroderma pigmentosum: a case report.
Şahin EA; Taşkıran EZ; Kiper PÖŞ; Aydın B; Utine E
J Med Case Rep; 2022 Jul; 16(1):306. PubMed ID: 35902966
[TBL] [Abstract][Full Text] [Related]
8. Xeroderma pigmentosum: a Turkish case series.
Gül U; Kiliç A; Gönül M; Cakmak SK; Soylu S
Int J Dermatol; 2007 Nov; 46(11):1125-8. PubMed ID: 17988329
[TBL] [Abstract][Full Text] [Related]
9. Basosquamous carcinoma and melanoma collision tumor in a child with xeroderma pigmentosum.
Bostanci S; Akay BN; Kirmizi A; Okcu Heper A; Farabi B
Pediatr Dermatol; 2020 Mar; 37(2):390-392. PubMed ID: 31957124
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of upper-left eyelid squamous cell carcinoma in an epidermodysplasia verruciformis patient by ALA-PDT/holmium laser combination therapy.
Chen Q; Jiang L; Shi L; Li C; Wu Y; Yang J; Zhang G; Wang X
Photodiagnosis Photodyn Ther; 2021 Jun; 34():102277. PubMed ID: 33819685
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
12. A combination of laser-assisted ALA-PDT for squamous cell carcinoma in situ and field-directed ALA-PDT for actinic keratosis.
Shen S; Liu X; Yang X; Hu C; Wang P; Wang X
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102638. PubMed ID: 34818597
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
14. Xeroderma pigmentosum: a case report and review of the literature.
Feller L; Wood NH; Motswaledi MH; Khammissa RA; Meyer M; Lemmer J
J Prev Med Hyg; 2010 Jun; 51(2):87-91. PubMed ID: 21155411
[TBL] [Abstract][Full Text] [Related]
15. Xeroderma Pigmentosum: Novel Prophylactic and Therapeutic Approaches. Part One: Topical Zinc Sulfate 25% and Heat Dermabrasion plus Topical Trichloroacetic Acid.
Sharquie K; Jabbar RI; Schwartz RA; Lambert MW; Lambert WC
Skinmed; 2023; 21(5):330-335. PubMed ID: 37945358
[TBL] [Abstract][Full Text] [Related]
16. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.
Kraemer KH; Lee MM; Andrews AD; Lambert WC
Arch Dermatol; 1994 Aug; 130(8):1018-21. PubMed ID: 8053698
[TBL] [Abstract][Full Text] [Related]
17. The effect of C-X-C motif chemokine ligand 13 in cutaneous squamous cell carcinoma treated with aminolevulinic acid-photodynamic therapy.
Zhu L; Zhang G; Wang P; Zhang L; Ji J; Liu X; Zhou Z; Zhao J; Wang X
Photodiagnosis Photodyn Ther; 2019 Jun; 26():389-394. PubMed ID: 31022580
[TBL] [Abstract][Full Text] [Related]
18. Two unusual tumors in a patient with xeroderma pigmentosum: atypical fibroxanthoma and basosquamous carcinoma.
Youssef N; Vabres P; Buisson T; Brousse N; Fraitag S
J Cutan Pathol; 1999 Oct; 26(9):430-5. PubMed ID: 10563498
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy for non-melanoma skin cancer.
Fien SM; Oseroff AR
J Natl Compr Canc Netw; 2007 May; 5(5):531-40. PubMed ID: 17509255
[TBL] [Abstract][Full Text] [Related]
20. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
